Int J Infect

Image Credit:Int J Infect

COVID-19 and Increasing Risk of Antimicrobial Resistance

Author(s):
Sama RahnemayanSama RahnemayanSama Rahnemayan ORCID1, Hamed Ebrahimzadeh LeylabadloHamed Ebrahimzadeh LeylabadloHamed Ebrahimzadeh Leylabadlo ORCID2, Sarvin SanaieSarvin SanaieSarvin Sanaie ORCID3, Reza GhotaslouReza GhotaslouReza Ghotaslou ORCID4,*
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
2Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
4Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

International Journal of Infection:Vol. 9, issue 1; e111443
Published online:May 18, 2021
Article type:Letter
Received:Nov 21, 2020
Accepted:Feb 03, 2021
How to Cite:Rahnemayan S, Ebrahimzadeh Leylabadlo H, Sanaie S, Ghotaslou R. COVID-19 and Increasing Risk of Antimicrobial Resistance. Int J Infect. 2022;9(1):e111443. doi: https://doi.org/10.5812/iji.111443

Dear editor,
In December 2019, Coronavirus disease 2019 (COVID-19) emerged in Wuhan, China, and spread all around the world in only a few weeks with a fatality rate of 2%. High transmission rate, besides fast infection onset, has raised a global concern against this virus. However, no vaccine or treatment has been found for this disease at present (1). The current outbreak of COVID-19 has turned most of us into germaphobes that rarely leave the house without having our bottle of hand sanitizer. For many years, hand sanitizers have gained our trust as destroyers of all microbes. However, it is better to be more cautious and think of their possible consequences before occurrence. Triclosan is a broad-spectrum antibacterial agent with bacteriostatic effects at low concentrations and has bactericidal effects at high concentrations. It is one of the ingredients previously used in some hand sanitizers. A study published in 2018 has shown that the triclosan in hand sanitizers just accelerates resistance to antibiotics in Escherichia coli only with 30 days of exposure to 0.2mg/L triclosan (2). Also, Staphylococcus aureus, as one of the potentially harmful bacteria of skin in humans seems to show resistance against antimicrobial agents as a result of exposure to triclosan (3). Active efflux is a resistance mechanism, involving reducing the drug concentration in bacteria, and after the long-term use of triclosan, this system drives the intracellular antibacterials out of the cell and causes resistance to triclosan and other antimicrobial drugs (4, 5). Triclosan and so many other ingredients were banned by the FDA in hand sanitizers; however, the exact impacts of other remaining ingredients are not clear and need time to be proven (6). Antimicrobial resistance is an important global health concern. According to the Centers for Disease Control and Prevention (CDC), antibiotic-resistant bacteria infect about 2.8 million people and result in more than 35,000 deaths annually in the United States (7). It is also important to notice that repeated use of alcohol-based hand sanitizers can cause skin dryness and makes it difficult to heal when injured. Besides, alcohol can kill the skin microbiome that consists of trillions of beneficial bacteria, viruses, and fungi. The skin microbiome acts as a natural defense against different pathogens and its breakdown may result in the development of chronic disease in the future (8). These outcomes together may build an even bigger threat, besides or after the coronavirus pandemic. Taking the current COVID-19 pandemic into consideration, using hand sanitizers is inevitable; but to avoid their important consequences, including antimicrobial resistance, some steps need to be taken. For instance, due to unclear aspects of ingredients in hand sanitizers, it may be better to limit their usage to places with higher rates of infection, including hospitals and health care centers. Finally, it is important to keep in mind that hand sanitizers carry zero advantages comparing to washing soaps, and it may be better for everyone's safety to replace them with soaps for daily usage.

Footnotes

References

  • 1.
    Valiei F, Leylabadlo HE, Ghotaslou A, Fallahi L, Ahmadian Z, Ghotaslou R. Role of dietary supplement in viral infection with an outlook on corona virus disease-2019. Reviews in Medical Microbiology. 2020;Publish Ahead of Print. https://doi.org/10.1097/mrm.0000000000000251.
  • 2.
    Lu J, Jin M, Nguyen SH, Mao L, Li J, Coin LJM, et al. Non-antibiotic antimicrobial triclosan induces multiple antibiotic resistance through genetic mutation. Environ Int. 2018;118:257-65. [PubMed ID: 29902774]. https://doi.org/10.1016/j.envint.2018.06.004.
  • 3.
    Yazdankhah SP, Scheie AA, Hoiby EA, Lunestad BT, Heir E, Fotland TO, et al. Triclosan and antimicrobial resistance in bacteria: an overview. Microb Drug Resist. 2006;12(2):83-90. [PubMed ID: 16922622]. https://doi.org/10.1089/mdr.2006.12.83.
  • 4.
    Sun Y, Hu X, Guo D, Shi C, Zhang C, Peng X, et al. Disinfectant resistance profiles and biofilm formation capacity of Escherichia coli isolated from retail chicken. Microb Drug Resist. 2019;25(5):703-11. [PubMed ID: 30614760]. https://doi.org/10.1089/mdr.2018.0175.
  • 5.
    Curiao T, Marchi E, Viti C, Oggioni MR, Baquero F, Martinez JL, et al. Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics. Antimicrob Agents Chemother. 2015;59(6):3413-23. [PubMed ID: 25824225]. [PubMed Central ID: PMC4432163]. https://doi.org/10.1128/AAC.00187-15.
  • 6.
    Atolani O, Baker MT, Adeyemi OS, Olanrewaju IR, Hamid AA, Ameen OM, et al. COVID-19: Critical discussion on the applications and implications of chemicals in sanitizers and disinfectants. EXCLI J. 2020;19:785-99. [PubMed ID: 32636732]. [PubMed Central ID: PMC7332783]. https://doi.org/10.17179/excli2020-1386.
  • 7.
    CDC. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S: Department of Health and Human Services CDC; 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
  • 8.
    Ishma T, Uddin H, Paul A, Feroz F, Acharjee M. Inhibitory effects of different hand sanitizers against the resident microflora of skin. Int J Sci Rep. 2019;5(12):355. https://doi.org/10.18203/issn.2454-2156.IntJSciRep20195300.

Similar Articles

11
Jul
2022
Arch Clin Infect Dis

Antimicrobial Resistance Patterns of Bacterial and Fungal Isolates in COVID-19

Rozita Khodashahi,
Hamid Reza Naderi,
Mosalreza Mohammadabadi,
Reza Ataei,
Mandana Khodashahi,
Maliheh Dadgarmoghaddam
,et al.

Khodashahi R, Naderi HR, Mohammadabadi M, Ataei R, Khodashahi M, et al. Antimicrobial Resistance Patterns of Bacterial and Fungal Isolates in COVID-19. Arch Clin Infect Dis. 2022;17(1):e121580. doi: https://doi.org/10.5812/archcid-121580

20
Sep
2025
J Inflamm Dis

A Lesson from a Pandemic for Health Professionals: The Impact of COVID-19 on the Spread of Treatment-Resistant Bacteria

Reza Abdollahi,
Mir Hossein Ahmadi

Abdollahi R, Ahmadi MH. A Lesson from a Pandemic for Health Professionals: The Impact of COVID-19 on the Spread of Treatment-Resistant Bacteria. J Inflamm Dis. 2025;29(2):e165707. doi: https://doi.org/10.69107/jid-165707

12
Jan
2025
Arch Clin Infect Dis

Evaluating the Antibiotic Resistance Pattern Before and After the COVID-19 Pandemic Among Cancer Patients

Azam Nabavi,
Sara Abolghasemi,
Masoud Mardani,
Mahdi Falah Tafti,
Niki Talebian,
Reza Ghasemi

Nabavi A, Abolghasemi S, Mardani M, Falah Tafti M, Talebian N, et al. Evaluating the Antibiotic Resistance Pattern Before and After the COVID-19 Pandemic Among Cancer Patients. Arch Clin Infect Dis. 2025;20(2):e150568. doi: https://doi.org/10.5812/archcid-150568

16
Sep
2020
Nephro-Urology Monthly

Strategies for Reducing the Risk of COVID-19 in Dialysis Patients

Behrouz Soltany,
Farzad Zareie

Soltany B, Zareie F. Strategies for Reducing the Risk of COVID-19 in Dialysis Patients. Nephro-Urol Mon. 2020;12(4):e107280. doi: https://doi.org/10.5812/numonthly.107280

1
Apr
2020
Archives of Clinical Infectious Diseases

Opportunities and Threats: The Necessity of Research in Dealing with the Rapid Spread of Coronavirus disease 2019 (COVID-19) in Iran

Abdorreza Naser Moghadasi

Naser Moghadasi A. Opportunities and Threats: The Necessity of Research in Dealing with the Rapid Spread of Coronavirus disease 2019 (COVID-19) in Iran. Arch Clin Infect Dis. 2020;15(COVID-19):e102809. doi: https://doi.org/10.5812/archcid.102809


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles